CASE REPORT
Aseptic meningitis complicating immunoglobulin therapy in AIDP
More details
Hide details
1
Tata Main Hospital, Jamshedpur, India
2
Lady Hardinge Medical College, University of Delhi, New Delhi, India
Submission date: 2015-11-25
Acceptance date: 2016-03-23
Online publication date: 2016-08-21
Publication date: 2019-12-15
Corresponding author
Ajit Kumar
HIG-19, Ground Floor, Sangam Vihar, Sonari, Jamshedpur, Jharkhand 831011, India. Tel.: +91 7763084855.
Pol. Ann. Med. 2017;24(1):52-54
KEYWORDS
ABSTRACT
Introduction:
A case of aseptic meningitis due to intravenous immunoglobulin is being reported.
Aim:
To learn rare side effect of intravenous immunoglobulin.
Case study:
Intravenous immunoglobulin is a safe therapy in many diseases. Side effects due to IVIG therapy usually are mild. Rarely can it lead to meningitis. We encountered aseptic meningitis in patientwith acute inflammatory demyelinating polyneuropathy following IVIG.
Results and discussion:
The incidence of drug-induced aseptic meningitis (DIAM) is unknown. Other drugs that have been associated with DIAM include NSAIDs, ranitidine, carbamazepine, vaccines against hepatitis B and mumps, immunoglobulin, and radiographic agents. Most of the reported cases had ITP as the primary disease or received high dose IVIG therapy. It has rarely been reported in patient with AIDP.
Conclusions:
Recognition of aseptic meningitis as an adverse reaction following IVIG therapy is important as it may be treated effectively.
CONFLICT OF INTEREST
None declared.
REFERENCES (6)
1.
Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22(3):215–226.
2.
Bhatt GC, Sharma T. Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency. J Pediatr Neurosci. 2012;7(3):242–243.
3.
Jarius S, Eichhorn P, Albert MH, et al. Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNF. Blood. 2007;109(10):4376–4382.
4.
Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol. 1994;97(suppl 1):79–83.
5.
Al-Ghamdi H, Mustafa MM, Al-Fawaz I, Al-Dowaish A. Acute aseptic meningitis associated with administration of immunoglobulin in children: a case report and review of the literature. Ann Saudi Med. 1999;19(4):362–364.
6.
Picton P, Chisholm M. Aseptic meningitis associated with high dose immunoglobulin: case report. BMJ. 1997;315(7117):1203–1204.